Richard Steven Morris's Net Worth
$377 Thousand
Who is Richard Steven Morris?
Richard Steven Morris does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Carisma Therapeutics Inc., Passage BIO, Inc., Vitae Pharmaceuticals, Inc, and VIROPHARMA INC.
SEC CIK
Richard Steven Morris's CIK is 0001432303
Past Insider Trading and Trends
2010 was Richard Steven Morris's most active year for acquiring shares with 5 total transactions. Richard Steven Morris's most active month to acquire stocks was the month of May. 2010 was Richard Steven Morris's most active year for disposing of shares, totalling 6 transactions. Richard Steven Morris's most active month to dispose stocks was the month of September. 2011 saw Richard Steven Morris paying a total of $40,560.00 for 14,000 shares, this is the most they've acquired in one year. In 2016 Richard Steven Morris cashed out on 238,001 shares for a total of $3,375,425.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Carisma Therapeutics Inc. (CARM) Snapshot price: $0.9803
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +66.13% | 2.17K |
$13.82 | $29,999.53 | 5.45K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
∞
| 400 |
$18.00 | $7,200.00 | 400 |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vitae Pharmaceuticals, Inc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -828.00 |
$21.00 | -$17,388.00 |
0
|
Oct 25
| |||
Form 4
|
∞
| 828 |
$6.11 | $5,059.08 | 828 |
Apr 29 - Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIROPHARMA INC No price found
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
$18.38 | -$29,453.06 | 1.24K |
Mar 9
| |||
Form 4
|
—
|
0
|
$19.81 | -$139,868.00 | 1.24K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
$21.44 | -$4,620.60 | 1.17K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
$9.91 | -$192,733.00 | 569 |
Dec 8 - Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| -84.88% | -2.20K |
$14.30 | -$31,453.77 | 392 |
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||